Skip to main content
Home ESG Stocks
Glaukos Corporation (GKOS) Stock Analysis & ESG Ratings
GKOS

Glaukos Corporation

Market overview

USD 176.70

Down−USD 2.86 (−1.59%) Day change

Open
USD 179.97
Previous close
USD 179.56
Day high
USD 180.14
Day low
USD 175.33
Volume
507,230
Market cap
USD 10,422,461,440

USD · Market data via Massive Stock Widgets · Last close · As of

Price chart · 1 Year
Glaukos Corporation 1 Year price chartGlaukos Corporation, nyse:GKOS, 1 Year price chart in USD. Start USD 93.95, end USD 176.70, high USD 189.55, low USD 74.67, up.
Period1 YearFirst closeUSD 93.95Last closeUSD 176.70Maximum closeUSD 189.55Minimum closeUSD 74.67Period change+USD 82.75Period percentage change+88.08%Chart as ofSep 1, 2026, 1:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 94.48 USD 95.57 USD 93.16 USD 93.95 467,100
USD 84.79 USD 88.93 USD 84.79 USD 87.17 707,700
USD 75.80 USD 76.08 USD 74.55 USD 74.67 1,309,100
USD 86.53 USD 90.61 USD 85.86 USD 88.07 1,634,400
USD 89.51 USD 92.60 USD 88.28 USD 88.40 984,500
USD 106.50 USD 109.31 USD 106.03 USD 107.46 763,100
USD 114.32 USD 116.72 USD 113.11 USD 113.21 739,500
USD 111.38 USD 113.81 USD 109.07 USD 112.28 718,600
USD 126.98 USD 130.23 USD 125.05 USD 125.90 1,437,300
USD 114.37 USD 114.97 USD 110.65 USD 112.52 951,600
USD 121.26 USD 122.48 USD 118.77 USD 119.17 540,600
USD 105.81 USD 106.78 USD 102.30 USD 103.15 875,000
USD 106.46 USD 109.67 USD 105.39 USD 109.60 706,200
USD 120.67 USD 120.96 USD 116.10 USD 116.40 522,100
USD 121.57 USD 124.38 USD 120.82 USD 122.07 802,400
USD 135.10 USD 137.20 USD 133.11 USD 136.36 667,100
USD 108.30 USD 111.05 USD 105.92 USD 106.52 1,563,800
USD 124.97 USD 128.27 USD 122.69 USD 126.81 708,000
USD 141.43 USD 141.74 USD 136.18 USD 139.76 1,086,100
USD 151.45 USD 157.71 USD 150.51 USD 156.84 630,500
USD 180.22 USD 184.00 USD 165.77 USD 168.52 2,559,600
USD 189.89 USD 190.00 USD 184.22 USD 184.53 743,400
USD 186.00 USD 190.06 USD 185.96 USD 189.55 505,300
USD 179.97 USD 180.14 USD 175.33 USD 176.70 507,230

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

Coverage PendingThird-Party ESG Coverage Under Review

Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Sustainability Strengths & Catalysts (Pros)

  • Published sustainability reporting: Glaukos released a 2025 Sustainability Report and publicizes sustainability initiatives overseen by its board, indicating formal disclosure and governance attention to ESG topics.
  • Regulatory and financial transparency: Glaukos regularly files SEC disclosures (including 8-Ks detailing operational and financial results) and provides investor presentations, supporting transparency for investors on business performance and risks.
  • Product focus on vision health: The company develops therapies and devices that address glaucoma and sight-preserving treatments, aligning its core business with positive health outcomes and potential patient quality-of-life benefits.

Material Risks & Governance Concerns (Cons)

  • Clinical and regulatory risk exposure: As a medical device and ophthalmic therapeutics company, Glaukos faces clinical trial, regulatory approval and post-market surveillance risks that can affect patient safety outcomes and company performance.
  • Operational and commercial concentration risks: Glaukos’s revenue relies heavily on adoption of its MIGS devices and related products in ophthalmic surgical markets, exposing the company to market competition, reimbursement pressures and single-sector dem

Company Profile & Business Model Overview

Financial & Valuation Fundamentals

Earnings Per Share (EPS)
$1.74
Dividend Yield
N/A

Data Integrity & Methodology Disclosure

Market quotes may be delayed and each visible snapshot states its source and observation time. ESG evaluations aggregate published ratings from MSCI ESG Research and Sustainalytics with normalized industry peer adjustments. Learn more in our ESG Rating Methodology.